niacinamide has been researched along with thiazoles in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (11.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (22.06) | 29.6817 |
| 2010's | 41 (60.29) | 24.3611 |
| 2020's | 4 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Pribyl, T; Schreiber, V | 1 |
| Goad, WC; Waring, PP; Ziporin, ZZ | 1 |
| Gorbach, ZV; Puzach, SS | 1 |
| Arai, Y; Hasegawa, S; Nakashita, H; Nishioka, M; Uramoto, M; Yamaguchi, I; Yasuda, M; Yoshida, S | 1 |
| Maruyama, T | 1 |
| BURCHENAL, JH; COLEY, V; OETTGEN, HF; REPPERT, JA | 1 |
| KRAKOFF, IH | 1 |
| BURCHENAL, JH; COLEY, VC; KRAKOFF, IH; OETTGEN, HF; PURPLE, JR | 1 |
| KARNOFSKY, DA; KRAKOFF, IH; LACON, CR | 1 |
| CIOTTI, CJ; GOLDIN, A; HUMPHREYS, SR; KAPLAN, NO; KLINE, I; VENDITTI, JM | 1 |
| Bilko, D; Newton, CJ; Renner, U; Stalla, GK; Tichomirowa, M | 1 |
| Curtiss, FR | 1 |
| Arnold, R; Bartsch, DK; Fendrich, V; Hörsch, D; Karhoff, D; Sauer, S; Schrader, J | 1 |
| von Mehren, M | 1 |
| Agaram, NP; Antonescu, CR; Besmer, P; Clarkson, BD; D'Adamo, D; DeMatteo, RP; Guo, T; Hom, G; Maki, RG; Schwartz, GK; Singer, S; Veach, D; Wong, GC | 1 |
| Thomas, X | 1 |
| Faivre, S; Le Tourneau, C; Raymond, E | 1 |
| Bui, B; Italiano, A | 1 |
| Dykens, JA; Hirakawa, B; Hynes, J; Jamieson, J; Jessen, BA; Marroquin, LD; Nadanaciva, S; Patyna, S; Will, Y | 1 |
| Clynes, M; Crown, J; Eustace, AJ; O'Donovan, N | 1 |
| Kiselyov, AS; Semenov, VV; Semenova, M | 1 |
| Decosterd, LA; Duchosal, MA; Haouala, A; Leyvraz, S; Montemurro, M; Ris, HB; Rochat, B; Widmer, N; Zaman, K; Zanolari, B | 1 |
| Gelderblom, H; Guchelaar, HJ; van Erp, NP | 1 |
| Bonvalot, S; Cioffi, A; Dômont, J; Le Cesne, A; Tardieu, M | 1 |
| Agostino, NM; Chinchilli, VM; Drabick, JJ; Gingrich, R; Koszyk-Szewczyk, A; Lynch, CJ; Sivik, J | 1 |
| Geoerger, B; Leblond, P | 1 |
| Blay, JY; Chaigneau, L; Curtit, E; Dobi, E; Kalbacher, E; Mansi, L; Nguyen, T; Pivot, X; Viel, E | 1 |
| Akita, K; Fujii, I; Gouda, M; Ishihama, Y; Kirii, Y; Kitagawa, D; Narumi, Y; Sugiyama, N; Yokota, K | 1 |
| Fan, D; Tang, L; Wang, J; Zhang, N; Zhang, Y | 1 |
| El-Gamal, MI; Lee, YS; Oh, CH; Park, JH | 1 |
| Armeanu-Ebinger, S; Dewerth, A; Eicher, C; Fuchs, J; Kirchner, B; Warmann, SW | 1 |
| Corey, SJ; Park, BJ; Whichard, ZL | 1 |
| Celeghini, C; Melloni, E; Norcio, A; Secchiero, P; Voltan, R; Zauli, G | 1 |
| Thurairatnam, S | 1 |
| Conn, PJ; Kiritoshi, T; Lindsley, CW; Neugebauer, V; Ren, W; Stauffer, SR; Sun, H | 1 |
| Biagioni, F; Conn, PJ; D'Amore, V; Jones, CK; Lindsley, CW; Molinaro, G; Ngomba, RT; Nicoletti, F; Prete, A; Rodriguez, AL; Santolini, I; Stauffer, SR; van Luijtelaar, G; van Rijn, CM; Vinson, PN; Zhou, Y | 1 |
| Claasen, J; Frenzel, LP; Gehrke, I; Hallek, M; Krause, G; Kuckertz, M; Patz, M; Veldurthy, A; Wendtner, CM | 1 |
| Balakrishnar, B; Clements, A; Gao, B; Gurney, H; Wong, M; Yeap, S | 1 |
| Chang, AY; Wang, M | 1 |
| Albizua, E; Arenas, A; Ayala, R; Barrio, S; Burgaleta, C; Gallardo, M; Gilsanz, F; Jiménez-Ubieto, A; Martinez-Lopez, J; Rapado, I; Rueda, D | 1 |
| Andriamanana, I; Duretz, B; Gana, I; Hulin, A | 1 |
| Robert, C; Sibaud, V | 1 |
| Beijnen, JH; de Vries, N; Schinkel, AH; Sparidans, RW; Tang, SC; Wagenaar, E | 1 |
| Catchot, A; Cook, D; Gore, J; Kerns, D; Leonard, BR; Lorenz, G; Stewart, SD | 1 |
| Bergot, E; Godinas, L; Guignabert, C; Humbert, M; Montani, D; Perros, F; Seferian, A; Sibille, Y | 1 |
| Bartz-Schmidt, KU; Bayyoud, T; Hofmann, J; Spitzer, M; Yoeruek, E | 1 |
| Fan, L; Han, TT; Li, JY; Xu, W | 1 |
| Chang, CC; Chang, JM; Chuang, SH; Huang, JJ; Huang, LY; Kao, KJ; Lau, JY; Lee, YS; Lin, HS; Liu, CW; Tsai, PY; Tsai, YJ | 1 |
| Chang, CC; Chang, JM; Chuang, SH; Huang, JJ; Huang, LY; Kao, KJ; Lau, GM; Lau, JY; Lee, YS; Lin, HS; Liu, CW; Tsai, PY | 1 |
| Andrews, G; Cook, AR; Cox, RJ; De Savi, C; Dearman, MS; Dickinson, MR; Gilmour, PS; McDonough, A; Morrill, LC; Parker, B; Riley, R; Warner, DJ; Young, SS | 1 |
| Beaune, P; de Waziers, I; Favre, A; Figg, WD; Kiehl, P; McMullen, J; Montemurro, M; Narjoz, C; Rochat, B | 1 |
| Ansari, MS; Conn, PJ; Daniels, JS; Emmitte, KA; Felts, AS; Jones, CK; Kessler, RM; Lindsley, CW; Niswender, CM; Rook, JM; Stauffer, SR; Tantawy, MN | 1 |
| Galanis, A; Levis, M | 1 |
| Baša Česnik, H; Bavčar, D; Leskovšek, R; Simončič, A; Stopar, M; Velikonja Bolta, Š | 1 |
| Bombard, S; Dingli, F; Kaiser, M; Kellermann, G; Lahuna, O; Loew, D; Mahuteau-Betzer, F; Naud-Martin, D; Ségal-Bendirdjian, E; Teulade-Fichou, MP | 1 |
| Guo, WH; Lu, J; Wang, XZ; Zhang, JX; Zheng, JF | 1 |
| Dong, X; Li, J; Li, T; Liu, F; Wang, F; Wang, X; Wang, Y; Wei, H; Xiu, P; Xu, Z; Zhong, J | 1 |
| Bollens, T; Pekas, A; Put, K; Wäckers, F | 1 |
| Chen, C; Lu, J; Wang, J; Zhang, Y; Zhou, M | 1 |
| Warren, RB; Yiu, ZZ | 1 |
| Ade, KK; Bhagat, S; Calakos, N; Conn, PJ; Dzirasa, K; Guo, W; Hamann, HC; Huber, KM; Kumar, S; O'Hare, JK; Quian, A; Rodriguiz, RM; Wan, Y; Wetsel, WC | 1 |
| Harada, A; Hirakawa, Y; Iwasa, S; Miyake, S; Narita, H; Yamasaki, T | 1 |
| Huang, YF; Jin, H; Li, Z; Lu, Z; Wang, X; Yu, C; Zhang, Q; Zhao, M | 1 |
| DeBoer, MD; Donowitz, JR; Gratz, J; Houpt, ER; Jatosh, S; McDermid, JM; Mduma, E; Platts-Mills, JA; Scharf, RJ; Svensen, E; Swann, JR; Wanjuhi, AW | 1 |
| DeBoer, MD; Donowitz, JR; Elwood, SE; Gratz, J; Houpt, ER; Jatosh, S; Katengu, S; Kivuyo, S; McDermid, JM; Mdoe, P; Mduma, E; Parpia, TC; Platts-Mills, JA; Rogawski McQuade, ET; Scharf, RJ; Svensen, E; Swann, JR; Wanjuhi, AW | 2 |
| Soussi-Yanicostas, N; Yanicostas, C | 1 |
| Bayo, E; Blacy, L; DeBoer, M; Elwood, S; Houpt, E; Mduma, E; Parpia, T; Platts-Mills, J; Rogawski McQuade, E; Scharf, R; Svensen, E; Wanjuhi, A | 1 |
15 review(s) available for niacinamide and thiazoles
| Article | Year |
|---|---|
[Pharmacotherapies for type 1 diabetes mellitus].
Topics: Adjuvants, Immunologic; Animals; Biguanides; Chaperonin 60; Diabetes Mellitus, Type 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Niacinamide; Peptide Fragments; Peptides; Regeneration; Sulfonylurea Compounds; Thiazoles | 2002 |
Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bevacizumab; Clinical Trials as Topic; Dasatinib; Drug Resistance, Neoplasm; Everolimus; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunosuppressive Agents; Indoles; Niacinamide; Oligonucleotides; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Sirolimus; Staurosporine; Sunitinib; Thiazoles | 2006 |
[Acute lymphoblastic leukemia with Philadelphia chromosome: treatment with kinase inhibitors].
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Benzamides; Benzenesulfonates; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indoles; Niacinamide; Phenylurea Compounds; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Sunitinib; Thiazoles | 2007 |
New developments in multitargeted therapy for patients with solid tumours.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzenesulfonates; Clinical Trials as Topic; Dasatinib; Drug Delivery Systems; Humans; Imatinib Mesylate; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Sunitinib; Thiazoles | 2008 |
[Gastrointestinal stromal tumors: molecular aspects and therapeutic implications].
Topics: Antineoplastic Agents; Benzamides; Benzenesulfonates; Disease Progression; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Mutation; Neoplasm Proteins; Niacinamide; Oligonucleotides; Phenylurea Compounds; Phthalazines; Piperazines; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Sorafenib; Staurosporine; Sunitinib; Thiazoles | 2008 |
Clinical pharmacokinetics of tyrosine kinase inhibitors.
Topics: Administration, Oral; Antineoplastic Agents; Benzamides; Benzenesulfonates; Biological Availability; Cytochrome P-450 Enzyme System; Dasatinib; Drug Interactions; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Indoles; Intestinal Absorption; Lapatinib; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thiazoles; Tissue Distribution | 2009 |
[Focus on GIST management].
Topics: Antineoplastic Agents; Benzamides; Benzenesulfonates; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Sunitinib; Thiazoles | 2010 |
[Indications and current development of new targeted therapies in pediatric oncology].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Benzenesulfonates; Bevacizumab; Child; Dasatinib; Erlotinib Hydrochloride; Hedgehog Proteins; Humans; Imatinib Mesylate; Indoles; Integrins; Molecular Targeted Therapy; Neoplasms; Niacinamide; Nifurtimox; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thiazoles; TOR Serine-Threonine Kinases | 2011 |
Hematopoietic prostaglandin D synthase inhibitors.
Topics: Alzheimer Disease; Animals; Asthma; Dermatitis, Atopic; Drug Design; Enzyme Inhibitors; Humans; Intramolecular Oxidoreductases; Leukodystrophy, Globoid Cell; Lipocalins; Muscular Dystrophies; Niacinamide; Piperidines; Pulmonary Disease, Chronic Obstructive; Pyrazoles; Pyrimidines; Rhinitis, Allergic, Perennial; Spinal Cord Injuries; Thiazoles | 2012 |
Evidence for therapeutic drug monitoring of targeted anticancer therapies.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Area Under Curve; Benzamides; Benzenesulfonates; Cetuximab; Dasatinib; Drug Monitoring; Everolimus; Evidence-Based Medicine; Half-Life; Humans; Imatinib Mesylate; Indoles; Injections, Intravenous; Molecular Targeted Therapy; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Rituximab; Sirolimus; Sorafenib; Sunitinib; Thiazoles | 2012 |
[Pigmentary disorders induced by anticancer agents. Part II: targeted therapies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Cetuximab; Dasatinib; ErbB Receptors; Humans; Imatinib Mesylate; Indazoles; Indoles; Ipilimumab; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Piperazines; Piperidines; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Sunitinib; Thiazoles | 2013 |
Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
Topics: Apoptosis; Benzamides; Cell Proliferation; Dasatinib; Endothelial Cells; ErbB Receptors; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Fibroblasts; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Niacinamide; Phenylurea Compounds; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pulmonary Circulation; Pyrimidines; Receptor Protein-Tyrosine Kinases; Sorafenib; src-Family Kinases; Thiazoles; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapy.
Topics: Aminopyridines; Antineoplastic Agents; Benzylamines; Chemokine CXCL12; Clinical Trials as Topic; Cyclams; Dasatinib; Heterocyclic Compounds; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Targeted Therapy; Morpholines; Niacinamide; Oxazines; Phenylurea Compounds; Protein Kinase Inhibitors; Purines; Pyridines; Pyrimidines; Quinazolinones; Receptors, CXCR4; Sorafenib; Thalidomide; Thiazoles; Tumor Microenvironment | 2014 |
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles | 2016 |
SDHI Fungicide Toxicity and Associated Adverse Outcome Pathways: What Can Zebrafish Tell Us?
Topics: Abnormalities, Multiple; Amides; Anilides; Animals; Biphenyl Compounds; Embryo, Nonmammalian; Energy Metabolism; Enzyme Inhibitors; Fish Proteins; Fungicides, Industrial; Gene Expression; Niacinamide; Norbornanes; Pyrazoles; Succinate Dehydrogenase; Thiazoles; Thiophenes; Zebrafish | 2021 |
4 trial(s) available for niacinamide and thiazoles
| Article | Year |
|---|---|
Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide.
Topics: Administration, Oral; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Breast Feeding; Double-Blind Method; Female; Growth and Development; Humans; Infant; Infant, Newborn; Male; Mothers; Niacinamide; Nitro Compounds; Randomized Controlled Trials as Topic; Tanzania; Thiazoles; Vitamin B Complex | 2018 |
Baseline Characteristics of Study Participants in the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial.
Topics: Adult; Azithromycin; Body Weight; Child Health; Child Nutrition Disorders; Child, Preschool; Cohort Studies; Early Medical Intervention; Female; Humans; Infant; Infant, Newborn; Male; Mothers; Neonatal Sepsis; Niacinamide; Nitro Compounds; Poverty; Respiratory Tract Infections; Rural Population; Seasons; Surveys and Questionnaires; Tanzania; Thiazoles; Young Adult | 2020 |
Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial.
Topics: Adult; Anti-Infective Agents; Azithromycin; Child Development; Double-Blind Method; Drug Administration Schedule; Female; Growth Disorders; Humans; Infant; Infant, Newborn; Intestinal Diseases, Parasitic; Niacinamide; Nitro Compounds; Pregnancy; Tanzania; Thiazoles | 2021 |
Cognitive Outcomes at 18 Months: Findings from the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial.
Topics: Anti-Infective Agents; Antiparasitic Agents; Azithromycin; Child Development; Cognitive Aging; Cohort Studies; Early Intervention, Educational; Female; Humans; Infant; Male; Niacinamide; Nitro Compounds; Seasons; Tanzania; Thiazoles; Vitamin B Complex | 2021 |
49 other study(ies) available for niacinamide and thiazoles
| Article | Year |
|---|---|
The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
Topics: 6-Aminonicotinamide; Animals; Ceruloplasmin; Estrogens; Female; Hexosephosphates; Male; Niacinamide; Oxythiamine; Pituitary Gland, Anterior; Rats; Thiazoles; Thyroxine-Binding Proteins | 1978 |
The use of thin-layer chromatography to separate thiamine and related compounds as well as N-methylnicotinamide and related compounds.
Topics: Chromatography, Thin Layer; Hydrogen-Ion Concentration; Methods; Niacinamide; Pyrimidines; Solvents; Sulfonic Acids; Thiamine; Thiazoles | 1968 |
[Method of determining thiaminase concentrations].
Topics: Alkyl and Aryl Transferases; In Vitro Techniques; Kinetics; Methods; Niacinamide; Thiazoles; Transferases | 1982 |
Chloroisonicotinamide derivative induces a broad range of disease resistance in rice and tobacco.
Topics: Bacteria; Fungi; Immunity, Innate; Isonicotinic Acids; Niacinamide; Nicotiana; Oryza; Plant Diseases; Plant Growth Regulators; Plants, Genetically Modified; Salicylic Acid; Signal Transduction; Soil; Thiadiazoles; Thiazoles; Tobacco Mosaic Virus | 2002 |
Effects of nicotinamide and related compounds on the antileukemic activity of 2-amino-1,3,4-thiadiazole.
Topics: Animals; Leukemia, Experimental; Niacin; Niacinamide; Nicotinic Acids; Thiadiazoles; Thiazoles | 1960 |
PURINE METABOLISM IN THE CHICK EMBRYO: INFLUENCE OF 2-SUBSTITUTED THIADIAZOLES.
Topics: Abnormalities, Drug-Induced; Allantoin; Animals; Carbon Isotopes; Chick Embryo; Chromatography; Formates; Hypoxanthines; Insulin; Metabolism; Methionine; Methionine Sulfoximine; NAD; Niacin; Niacinamide; Nucleosides; Purines; Pyridines; Research; Serine; Sulfanilamide; Sulfanilamides; Thiadiazoles; Thiazoles; Toxicology; Triazines; Uric Acid; Uricosuric Agents | 1964 |
POTENTIATION OF THE ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE AND DERIVATIVES.
Topics: Amides; Animals; Antineoplastic Agents; Isonicotinic Acids; Leukemia; Leukemia L1210; Leukemia, Experimental; Mice; Niacinamide; Pharmacology; Pyridines; Research; Thiadiazoles; Thiazoles | 1964 |
Reversal of effects of 2-substituted thiadiazoles by nicotinamide analogues and precursors.
Topics: Niacin; Niacinamide; Nicotinic Acids; Organic Chemicals; Thiadiazoles; Thiazoles | 1959 |
Toxicity and antileukemic effectiveness of pyridine derivatives and 1,3,4-thiadiazole derivatives in mice. Relationship to nicotinamide antagonism.
Topics: Animals; Antineoplastic Agents; Leukemia, Experimental; Mice; Niacin; Niacinamide; Nicotinic Acids; Pyridines; Thiadiazoles; Thiazoles | 1962 |
The role of poly (adenosine 5'-diphosphate-ribose) polymerase in the response of pituitary tumor cells to reactive oxygen species.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Benzamides; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; DNA Fragmentation; Dose-Response Relationship, Drug; Endothelium, Vascular; Glucose; Humans; Hydrogen Peroxide; L-Lactate Dehydrogenase; Membrane Potentials; Mitochondria; Niacinamide; Oxidants; Pituitary Neoplasms; Poly(ADP-ribose) Polymerases; Rats; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Time Factors; Umbilical Veins | 2005 |
Pharmacy benefit spending on oral chemotherapy drugs.
Topics: Administration, Oral; Ambulatory Care; Antineoplastic Agents; Benzamides; Benzenesulfonates; Capecitabine; Dasatinib; Deoxycytidine; Drug Costs; Employer Health Costs; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Health Benefit Plans, Employee; Humans; Imatinib Mesylate; Indoles; Insurance, Pharmaceutical Services; Lenalidomide; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Prescription Fees; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thalidomide; Thiazoles; United States | 2006 |
Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target.
Topics: Benzenesulfonates; Digestive System Neoplasms; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Neuroendocrine Tumors; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Pyridines; raf Kinases; rap1 GTP-Binding Proteins; Signal Transduction; Sorafenib; Tetrazolium Salts; Thiazoles | 2007 |
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Benzenesulfonates; Cell Proliferation; Dasatinib; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mice; Mutation; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Sorafenib; Thiazoles | 2007 |
Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells.
Topics: Adenosine Triphosphate; Animals; Benzamides; Benzenesulfonates; Cell Survival; Dasatinib; Dose-Response Relationship, Drug; Electron Transport; Galactose; Glucose; Imatinib Mesylate; Indoles; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Niacinamide; Oxidative Phosphorylation; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Sorafenib; Sunitinib; Thiazoles | 2008 |
Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dacarbazine; Dasatinib; Drug Screening Assays, Antitumor; Drug Synergism; Focal Adhesion Protein-Tyrosine Kinases; Humans; Melanoma; Neoplasm Invasiveness; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Pyridines; Pyrimidines; Receptor, EphA2; Sorafenib; Temozolomide; Thiazoles | 2008 |
3,4-Disubstituted isothiazoles: novel potent inhibitors of VEGF receptors 1 and 2.
Topics: Adenosine Triphosphate; Caco-2 Cells; Combinatorial Chemistry Techniques; Drug Design; Humans; Indoles; Molecular Structure; Niacinamide; Oligonucleotides; Phthalazines; Pyridines; Structure-Activity Relationship; Thiazoles; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Topics: Antineoplastic Agents; Benzamides; Benzenesulfonates; Chromatography, Liquid; Dasatinib; Drug Monitoring; Humans; Imatinib Mesylate; Indoles; Lapatinib; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Tandem Mass Spectrometry; Thiazoles | 2009 |
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice.
Topics: Aged; Antineoplastic Agents; Benzamides; Benzenesulfonates; Blood Glucose; Dasatinib; Diabetes Mellitus; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Imatinib Mesylate; Indoles; Linear Models; Male; Middle Aged; Neoplasms; Niacinamide; Pennsylvania; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Sorafenib; Sunitinib; Thiazoles; Time Factors; Treatment Outcome | 2011 |
[KIT and KIT: from biology to clinical use].
Topics: Antineoplastic Agents; Benzamides; Benzenesulfonates; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Sunitinib; Thiazoles | 2012 |
Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase.
Topics: Animals; Benzamides; Benzenesulfonates; Binding, Competitive; Cell Line; Dasatinib; Dose-Response Relationship, Drug; Humans; Imatinib Mesylate; Indazoles; Indoles; Kinetics; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Sorafenib; Spodoptera; Staurosporine; Sulfonamides; Sunitinib; Surface Plasmon Resonance; Thiazoles; Transfection | 2012 |
Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Annexin A5; Blotting, Western; Cell Death; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Antibody Technique; Humans; Mitochondria; Motor Neurons; Mutation; Neuroprotective Agents; Niacinamide; Propidium; Real-Time Polymerase Chain Reaction; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1; Tetrazolium Salts; Thiazoles; Up-Regulation | 2011 |
New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Topics: Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Imidazoles; Melanoma; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Structure-Activity Relationship; Thiazoles | 2011 |
Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1 nu mice.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Fluorescent Antibody Technique, Indirect; Forkhead Transcription Factors; Hepatoblastoma; In Situ Nick-End Labeling; Mice; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Transplants | 2012 |
Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Breast Neoplasms; Butadienes; Cell Line, Tumor; Chromones; Dasatinib; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epothilones; Female; Humans; Morpholines; Niacinamide; Nitriles; Paclitaxel; Phenylurea Compounds; Pyridines; Pyrimidines; Signal Transduction; Sirolimus; Sorafenib; Tamoxifen; Thiazoles | 2012 |
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.
Topics: Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Dasatinib; Down-Regulation; Humans; Leukemia, Myeloid, Acute; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyridines; Pyrimidines; Sorafenib; Thiazoles | 2012 |
Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glycine; Inhibitory Postsynaptic Potentials; Male; Morpholines; Neural Inhibition; Niacinamide; Phenylacetates; Prefrontal Cortex; Pyramidal Cells; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thiazoles | 2013 |
Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats.
Topics: Age Factors; Animals; Brain Waves; Cerebral Cortex; Disease Models, Animal; Electroencephalography; Epilepsy, Absence; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hydrolysis; Male; Motor Activity; Niacinamide; Phosphatidylinositol Phosphates; Pyridines; Rats; Rats, Inbred Strains; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Somatosensory Cortex; Thiazoles; Ventral Thalamic Nuclei | 2013 |
Comparison of the effects of two kinase inhibitors, sorafenib and dasatinib, on chronic lymphocytic leukemia cells.
Topics: Benzenesulfonates; Cell Survival; Dasatinib; Dose-Response Relationship, Drug; Humans; Lethal Dose 50; Leukemia, Lymphocytic, Chronic, B-Cell; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Sorafenib; Thiazoles; Treatment Outcome; Tumor Cells, Cultured | 2012 |
In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma.
Topics: Alanine; alpha-Fetoproteins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Hepatocellular; Cetuximab; Dasatinib; Doxorubicin; Drug Screening Assays, Antitumor; Epothilones; Gefitinib; Humans; Indoles; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperidines; Pyridones; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thiazoles; Triazines | 2013 |
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cell Proliferation; Cells, Cultured; Chronic Disease; Dasatinib; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Janus Kinase 2; Janus Kinases; Male; Middle Aged; Myeloproliferative Disorders; Niacinamide; Nitriles; Phenylurea Compounds; Phosphorylcholine; Polycythemia Vera; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrrolidinones; Signal Transduction; Sorafenib; STAT5 Transcription Factor; Thiazoles; Thrombocythemia, Essential; Tumor Cells, Cultured | 2013 |
Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
Topics: Antineoplastic Agents; Benzamides; Boronic Acids; Bortezomib; Chromatography, Liquid; Dasatinib; Erlotinib Hydrochloride; Humans; Imatinib Mesylate; Indoles; Lapatinib; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Pyrazines; Pyrimidines; Pyrroles; Quinazolines; Reproducibility of Results; Sorafenib; Sunitinib; Tandem Mass Spectrometry; Thiazoles | 2013 |
Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) gene dosage on plasma pharmacokinetics and brain accumulation of dasatinib, sorafenib, and sunitinib.
Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Brain; Dasatinib; DNA, Complementary; Female; Gene Dosage; Half-Life; Indoles; Male; Maternal-Fetal Exchange; Mice; Mice, Knockout; Niacinamide; Phenylurea Compounds; Pregnancy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Real-Time Polymerase Chain Reaction; RNA; Sex Characteristics; Sorafenib; Sunitinib; Thiazoles | 2013 |
Cotton aphid (Heteroptera: Aphididae) susceptibility to commercial and experimental insecticides in the southern United States.
Topics: Animals; Aphids; Biological Assay; Dose-Response Relationship, Drug; Insecticide Resistance; Insecticides; Lethal Dose 50; Neonicotinoids; Niacinamide; Nitro Compounds; Nymph; Oxazines; Pyridines; Selection, Genetic; Southeastern United States; Sulfur Compounds; Texas; Thiamethoxam; Thiazoles | 2013 |
Cytotoxic properties of sunitinib and sorafenib on human corneal epithelial cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biomarkers; Cell Line; Cell Survival; Enzyme-Linked Immunosorbent Assay; Epithelium, Corneal; Humans; Immunohistochemistry; Indoles; Membrane Proteins; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Sorafenib; Sunitinib; Tetrazolium Salts; Thiazoles | 2014 |
Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1.
Topics: Adenocarcinoma; Administration, Intravenous; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytoskeletal Proteins; Drug Synergism; Female; Gene Knockdown Techniques; Lung Neoplasms; Male; Mice; Mice, Nude; Niacinamide; NIMA-Related Kinases; Nuclear Proteins; Protein Serine-Threonine Kinases; Proteolysis; Retinoblastoma Protein; Thiazoles; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cytoskeletal Proteins; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 4 or More Rings; Humans; In Vitro Techniques; MCF-7 Cells; Mice; Molecular Targeted Therapy; Niacinamide; Nuclear Proteins; Thiazoles; Xenograft Model Antitumor Assays | 2014 |
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Benzamides; Dogs; Ferrets; Humans; Lipopolysaccharides; Lung; Neutrophils; Niacinamide; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Vomiting | 2014 |
Important role of CYP2J2 in protein kinase inhibitor degradation: a possible role in intratumor drug disposition and resistance.
Topics: Benzamides; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dasatinib; Hep G2 Cells; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Sunitinib; Thiazoles | 2014 |
Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles.
Topics: Allosteric Regulation; Amphetamine; Animals; Benzamides; Calcium; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Locomotion; Male; Maze Learning; Niacinamide; Piperidines; Positron-Emission Tomography; Radioligand Assay; Rats; Receptor, Metabotropic Glutamate 5; Structure-Activity Relationship; Thiazoles | 2015 |
Inhibition of c-Kit by tyrosine kinase inhibitors.
Topics: Aminopyridines; Antineoplastic Agents; Benzothiazoles; Biomarkers; Bone Marrow; Cell Line, Tumor; Clinical Trials as Topic; Dasatinib; fms-Like Tyrosine Kinase 3; Gene Expression; Hair; Hematopoietic Stem Cells; Humans; Indazoles; Leukemia, Myeloid, Acute; Niacinamide; Phenylurea Compounds; Pigmentation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Thiazoles | 2015 |
Integrated pest management of "Golden Delicious" apples.
Topics: Acaricides; Biphenyl Compounds; Carbamates; Crops, Agricultural; Crosses, Genetic; European Union; Food Contamination; Food Quality; Fruit; Fungicides, Industrial; Guidelines as Topic; Humans; Insecticides; Malus; Neonicotinoids; Niacinamide; Nitro Compounds; Oxazines; Pest Control; Pesticide Residues; Pyrazoles; Pyridines; Risk Assessment; Slovenia; Strobilurins; Thiamethoxam; Thiazines; Thiazoles | 2015 |
Identification of human telomerase assembly inhibitors enabled by a novel method to produce hTERT.
Topics: Acridines; Genetic Techniques; HEK293 Cells; Humans; Niacinamide; Recombinant Fusion Proteins; RNA; RNA Folding; Small Molecule Libraries; Structure-Activity Relationship; Telomerase; Thiazoles; Trisaccharides | 2015 |
Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy.
Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Synergism; Everolimus; Fluorescein-5-isothiocyanate; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways; Metabolomics; Multivariate Analysis; Niacinamide; Phenylurea Compounds; Sorafenib; Tetrazolium Salts; Thiazoles | 2015 |
Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Meloxicam; Mice; Niacinamide; Phenylurea Compounds; Sorafenib; Thiazines; Thiazoles; Xenograft Model Antitumor Assays | 2015 |
Non-target effects of commonly used plant protection products in roses on the predatory mite Euseius gallicus Kreiter & Tixier (Acari: Phytoseidae).
Topics: Acaricides; Acetates; Animals; Fungicides, Industrial; Imidazoles; Limonins; Mites; Naphthalenes; Neonicotinoids; Niacinamide; Nitro Compounds; Oxazines; Oxazoles; Pyridines; Rosa; Thiamethoxam; Thiazines; Thiazoles | 2016 |
Baseline sensitivity and resistance risk assessmemt of Rhizoctonia cerealis to thifluzamide, a succinate dehydrogenase inhibitor.
Topics: Anilides; Biphenyl Compounds; Drug Resistance, Fungal; Fungicides, Industrial; Herbicides; Niacinamide; Rhizoctonia; Succinate Dehydrogenase; Thiazoles; Triticum | 2015 |
Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice.
Topics: Animals; Behavior, Animal; Corpus Striatum; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Grooming; Mice; Mice, Knockout; Mice, Transgenic; Nerve Tissue Proteins; Niacinamide; Obsessive-Compulsive Disorder; Pyridines; Receptor, Metabotropic Glutamate 5; Signal Transduction; Thiazoles | 2016 |
Development of an Immunosensor Based on Surface Plasmon Resonance for Simultaneous Residue Analysis of Three Pesticides -Boscalid, Clothianidin, and Nitenpyram- in Vegetables.
Topics: Biosensing Techniques; Biphenyl Compounds; Enzyme-Linked Immunosorbent Assay; Guanidines; Molecular Structure; Neonicotinoids; Niacinamide; Pesticide Residues; Surface Plasmon Resonance; Thiazoles; Vegetables | 2018 |
Simultaneous determination of nine neonicotinoids in human urine using isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Child; China; Chromatography, High Pressure Liquid; Environmental Monitoring; Guanidines; Humans; Indicator Dilution Techniques; Insecticides; Isotopes; Neonicotinoids; Niacinamide; Nitro Compounds; Oxazines; Pyridines; Tandem Mass Spectrometry; Thiamethoxam; Thiazines; Thiazoles | 2018 |